High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: A cross-sectional study

Keyphrases

• Diabetic Patients 100%
• Normal Blood 100%
• Type 2 Diabetes Mellitus Patients 100%
• Blood Platelets 100%
• Ischemic Events 100%
• High-risk Types 100%
• Diabetic Control 50%
• Platelet-leukocyte Aggregates 50%
• Platelets 37%
• High Risk 12%
• Type 2 Diabetes Mellitus (T2DM) 12%
• PAC1 12%
• Primary Prevention 12%
• Leukocytes 12%
• Blood Samples 12%
• Vascular Disease 12%
• Aspirin 12%
• Vascular Complications 12%
• Induced Aggregation 12%
• Antiplatelet Agents 12%
• Secondary Prevention 12%
• Induced Activation 12%
• Antiplatelet Drugs 12%
• Type 2 Diabetic Patients 12%
• Fasting Plasma Glucose 12%
• Non-diabetic 12%
• Mean Platelet Volume 12%
• P-selectin Expression 12%
• Platelet Markers 12%
• Vasculopathic 12%
• Stimulus-induced 12%

Medicine and Dentistry

• Cross Sectional Study 100%
• Platelet 100%
• Maturity Onset Diabetes of the Young 100%
• Diabetes Mellitus 100%
• Thrombocyte Aggregation 44%
• Leukocyte 33%
• Drug Therapy 11%
• Antiplatelet 11%
• Neutrophil 11%
• Disease Predisposition 11%
• Acetylsalicylic Acid 11%
• Monocyte 11%
• PADGEM Protein 11%
• Antiplatelet Drug 11%
• Secondary Prevention 11%
• Patient with Type 2 Diabetes 11%
• Primary Prevention 11%
• Vascular Disease 11%
• Mean Platelet Volume 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Insulin Dependent Diabetes Mellitus 100%
• Cross-Sectional Study 100%
• Diabetes Mellitus 100%
• P-Selectin 11%
• Antiplatelet 11%
• Acetylsalicylic Acid 11%
• Antithrombocytic Agent 11%
• Disease Predisposition 11%
• Vascular Disease 11%